IVI RMA North America Unveils Artemis Platform and AiVA AI Assistant, a First-of-Its-Kind AI-Powered Tool for Reproductive Medicine to Advance Personalized, Patient-Centered Care
Proprietary Platform Uses AI to Surface Important Insights, Enhance Clinical Intelligence, Anticipate Patient Needs,
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
![]()
IVI RMA North America, a leader in fertility care and assisted reproduction, today unveiled AiVA AI Assistant, its breakthrough AI capability, designed to advance personalized, patient-centered care. AiVA is built on Artemis, IVI RMA North America’s proprietary, fertility-specific technology platform.
“Artemis was built from the ground up because no other technology platform could support the complexity of fertility care and give our teams the tools they need to deliver the high standard of care we are committed to provide throughout each patient’s treatment journey,” said Dr. Thomas Molinaro, Chief Medical Officer, IVI RMA North America. “AiVA AI Assistant establishes a new technology foundation for reproductive medicine—one that brings truly personalized care and can continuously evolve alongside our physicians, our care teams, and the patients we serve.”
Artemis is grounded in unmatched reproductive medicine knowledge and longitudinal patient and clinical data from one of North America’s largest and most sophisticated fertility networks. Because it was developed within a fertility practice and shaped by fertility experts, Artemis is uniquely able to meet the specific needs of reproductive medicine.
Breakthrough AI Capability
At the heart of Artemis is the AiVA AI Assistant, a breakthrough AI capability. Key features include:
- Connects the patient chart to the collective expertise of more than 100 fertility experts across the network, and insights from hundreds of thousands of prior cases to identify patterns and connections to inform personalized patient care.
- Makes that intelligence accessible to doctors anytime, anywhere, so individual patients at any of the network’s clinics can truly benefit from the totality of the organization’s knowledge.
- Helps clinicians make faster, better-informed decisions by turning fragmented chart data, prior cycles, labs, embryology, notes, and outside records into a clear clinical picture in seconds.
- Reduces documentation and administrative burden by drafting chart-ready notes, patient messages, summaries, and follow-up plans in the clinician’s preferred format, giving providers more time to focus on patients.
- Brings greater consistency to care by embedding proven clinical workflows, treatment logic, and operational best practices into the daily practice of fertility medicine.
A Comprehensive Fertility Platform
The rest of the Artemis platform brings together a suite of capabilities spanning patient navigation, clinical intelligence, physician workflow, communications, and organizational insight into a clinical operating system. Highlights include:
- Artemis Care Compass helps providers keep patients moving forward with their personalized treatment plans and proactively stay on track with timely next steps.
- AiVA Talk uses ambient AI to streamline clinical documentation, giving physicians more time to focus on patients. The technology is estimated to save each physician 35 to 110 minutes per day, depending on their patient volume, creating additional capacity for patient engagement and care.
- Artemis Messenger enables real-time communication between patients and care teams within the Artemis ecosystem. AI extracts and summarizes documents, saving patients and providers valuable time and ensuring key information is saved and categorized.
- Artemis Insights gives leadership a real-time view of clinical and operational trends to support organizational decision-making.
Another of Artemis’ most distinctive capabilities, Artemis Pulse Check, uses AI to give IVI RMA leadership near real-time insight into what matters most to patients, what is working well and opportunities to enhance the care experience. Artemis turns those insights into actionable recommendations across operations, finance, communications and other areas of the organization.
“Artemis is tangible proof of use of advanced technology to help deliver an exceptional experience for every patient, at every clinic,” said Lynn Mason, CEO, IVI RMA North America. “Operating from a single technology platform across our network gives us an extraordinary opportunity to share knowledge, learn from our patients, and continuously strengthen how we deliver care and strengthen the patient experience across our network.”
Dedicated Team Bringing Cutting Edge Fertility AI to the Largest Global Fertility Network
“A dedicated team of nearly 34 engineers has been building, testing, deploying, supporting, and maintaining Artemis’ suite of tools to effectively utilize AI across our clinics and labs,” added James DiLella, VP of Software Engineering and Global Head of New EHR, at IVI RMA North America. “I couldn’t be prouder that we are finally pulling back the curtain on AiVA’s rollout across our U.S. network and the transformative effect this will have on our operations and on patient care.”
Built on nearly 30 years of fertility experience and a culture of high performance, Artemis is designed to help translate exceptional clinical knowledge into scalable, repeatable, high-quality patient care. Artemis is already deployed at more than 60 clinics across North America and sees approximately 2,000 users accessing the platform during a typical workday. In the coming years, IVI RMA has plans to expand the platform across its international network of more than 200 locations across 15 countries.
About IVI RMA North America
IVI RMA North America, comprising Reproductive Medicine Associates, Boston IVF, and Toronto-based TRIO, spans more than 70 clinics and 27 IVF laboratories and has helped women and couples achieve pregnancies leading to the birth of over 220,000 babies to date. Pioneers in innovative care, including PGT-A, single embryo transfer, fertility preservation, LGBTQ+ care, and more, the network has published over 1,000 papers which have pushed the fertility industry forward. IVI RMA North America is part of IVI RMA Global, the world’s leading reproductive medicine group committed to providing evidence-based fertility solutions to patients seeking treatment anywhere in the world. IVI RMA Global employs more than 6,000 people across 200+ locations in 15 countries. Learn more at rmanetwork.com and ivirma.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261008198259/en/
Media gallery